2024MAY03: Our hosting provider has resolved some DB connectivity issues. We may experience some more outages as the issue is resolved. We apologize for the inconvenience. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Choroid plexus-CSF-targeted antioxidant therapy protects the brain from toxicity of cancer chemotherapy.

Neuron | 2022

For many cancer patients, chemotherapy produces untreatable life-long neurologic effects termed chemotherapy-related cognitive impairment (CRCI). We discovered that the chemotherapy methotrexate (MTX) adversely affects oxidative metabolism of non-cancerous choroid plexus (ChP) cells and the cerebrospinal fluid (CSF). We used a ChP-targeted adeno-associated viral (AAV) vector approach in mice to augment CSF levels of the secreted antioxidant SOD3. AAV-SOD3 gene therapy increased oxidative defense capacity of the CSF and prevented MTX-induced lipid peroxidation in the hippocampus. Furthermore, this gene therapy prevented anxiety and deficits in short-term learning and memory caused by MTX. MTX-induced oxidative damage to cultured human cortical neurons and analyses of CSF samples from MTX-treated lymphoma patients demonstrated that MTX diminishes antioxidant capacity of patient CSF. Collectively, our findings motivate the advancement of ChP- and CSF-targeted anti-oxidative prophylactic measures to relieve CRCI.

Pubmed ID: 36070751 RIS Download

Associated grants

  • Agency: NINDS NIH HHS, United States
    Id: R01 NS088566
  • Agency: NICHD NIH HHS, United States
    Id: P50 HD105351
  • Agency: NEI NIH HHS, United States
    Id: P30 EY012196
  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM144273
  • Agency: NCI NIH HHS, United States
    Id: R01 CA222598
  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM007753
  • Agency: NICHD NIH HHS, United States
    Id: U54 HD090255

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Normal Goat Serum (antibody)

RRID:AB_2336990

This unknown targets Goat Serum

View all literature mentions

Anti-rabbit IgG, HRP-linked Antibody (antibody)

RRID:AB_2099233

This polyclonal secondary targets IgG

View all literature mentions

Vinculin (E1E9V) XP® (antibody)

RRID:AB_2728768

This monoclonal targets Vinculin

View all literature mentions

Anti-GFP antibody (antibody)

RRID:AB_300798

This polyclonal targets GFP

View all literature mentions

Albumin Antibody (antibody)

RRID:AB_2225785

This polyclonal targets Albumin

View all literature mentions

GraphPad Prism (software resource)

RRID:SCR_002798

Statistical analysis software that combines scientific graphing, comprehensive curve fitting (nonlinear regression), understandable statistics, and data organization. Designed for biological research applications in pharmacology, physiology, and other biological fields for data analysis, hypothesis testing, and modeling.

View all literature mentions

Fiji (software resource)

RRID:SCR_002285

Software package as distribution of ImageJ and ImageJ2 together with Java, Java3D and plugins organized into coherent menu structure. Used to assist research in life sciences.

View all literature mentions

B6.129P2(Cg)-Cx3cr1tm1Litt/J (organism)

RRID:IMSR_JAX:005582

Mus musculus with name B6.129P2(Cg)-Cx3cr1tm1Litt/J from IMSR.

View all literature mentions